Bristol-Myers Squibb (BMY) discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Three key data points gauge Bristol-Myers Squibb or any dividend paying firm.

The key three are:

(1) Price

(2) Dividends

(3) Returns

Those three keys also best tell whether any company has made, is making, and will make money.

BMY Price

Over the past year, Bristol-Myers share price dropped about 17.4% from $59.49 to $49.13 as of Friday’s market close. In the past thirty years the company’s share price has never been less than $13.66 nor higher than $81.44.

If BMY shares trade in the range of $40.00 to $55.00 this next year, the recent $49.13 share price might rise by $3.87 to reach $53.00 in a year. Of course, BMY price could also drop about the same $3.87 estimated amount, or more.

My $3.87 upside estimate is  $0.34 under the median of 1-year price targets from 21 analysts currently tracking BMY for brokers.

BMY Dividend

Bristol-Myers Squibb has paid annually increasing quarterly dividends since February 1985.  The most recent $0.60 Q dividend was declared September 10th for shareholders of record October 4th and is payable November 1st.  There’s time to fetch this payout!  A forward looking $2.40 annual dividend yields 4.88% at Friday’s closing price.

BMY Returns

Putting it all together, a $6.27 estimated one year gross gain per share shows up when adding BMY’s $2.40 estimated annual dividend to the estimated price upside of $3.87, making that $6.27 gross gain per share total.

A little under $1000 buys us 20 shares at the $49.13 share price.

A $10 broker fee (if charged), paid half at purchase and half at sale, might take about $0.50 per share out of the $6.27 annual estimated gross-gain to give us a net gain of $5.77 X 20 shares = $115.40 for about a 11.5% estimated net gain for the year.

Furthermore, the $48.80 annual dividend income from $1K invested is just $0.33 under the BMY single share price. By these numbers, Bristol-Myers Squibb may be an ideal dividend dog when its price drops to (or below) $49.00.

Then, you might choose to pounce on Bristol-Myers Squibb It is a 137 year-old quarterly dividend-paying New Jersey-based pharmaceutical with a 39 year record paying uninterrupted quarterly dividends.

The exact track of Bristol-Myers Squibb’s future price and dividend will entirely be determined by market action.

Remember, the true value of any stock is best realized through personal ownership of shares.

More By This Author:

Current Report: Mercedes Benz Group
Current Report: Kingfisher
Current Report: Johnson Electric